August 15 2018 - FDA to soon rule on Roche’s Tecentriq for first line NSCLC

FDA to soon rule on Roche’s Tecentriq for first line NSCLC
What’s next for Spark Therapeutics
Biogen’s Spinraza gets negative from NICE
Long-acting injection boosts hope for GSK’s HIV biz
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com